ArticleHepatitis monthly2012

Treatment Response and Tolerability of Pegylated Interferon-α Plus Ribavirin Combination Therapy in elderly Patients (≥ 65 years) With Chronic Hepatitis C in Korea.

Hyeong Il Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.